Elsevier,

Australian and New Zealand Journal of Public Health, Volume 48, June 2024

Māori and Pacific people want to take charge of their heart health but face challenges. Participants described important obligations to family, community and tikanga (the culturally correct way of doing things). Participants described times when health care undermined existing responsibilities, their dignity and/or their mana, and they felt excluded from treatment as a result.

The paper assesses the feasibility of using the Canadian Health Measures Survey (CHMS) data to analyze chemical exposures in racial and Indigenous populations in Canada, and discusses the opportunities and constraints of this analysis, while noting the limited representativeness of Indigenous identity groups in the CHMS sample.

Review evidence on the burden of chronic respiratory diseases in Indigenous peoples globally, summarise factors that underlie health disparities between Indigenous and non-Indigenous people, propose a framework of approaches to improve the respiratory health of Indigenous peoples, and outline future directions for clinical care and research

Elsevier,

Metabolic Steatotic Liver Disease: Current Knowledge, Therapeutic Treatments, and Future Directions, 2024, Pages 261-275

This content aligns with Goal 3: Good Health as this chapter will review the aspects of combined viral hepatitis and FLD, including prevalence, risk factors, natural history, pathogenesis, and management to help inform the reader of the complexity of these liver diseases.

Elsevier,

Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, pp 955-971

This content aligns with Goal 3: Good Health and Goal 10: Reduced Inequalities by exploring the World Mental Health Report, which discusses the topic of mental health drivers and access to community mental health care in countries across the globe.
Elsevier,

Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, Pages 713-727

This content aligns with Goal 3: Good Health by emphasizing the importance of overcoming barriers to ensure equitable access to health and well-being for individuals with various impairments, thus promoting inclusive participation in society. It also supports Goal 10: Reduced Inequalities by advocating for the development and implementation of digital and assistive technologies that empower people with disabilities, ensuring they have equal opportunities and resources. The call for disability-inclusive policies during the recovery from the COVID-19 pandemic further underscores the commitment to achieving social inclusion and the United Nations’ Sustainable Development Goals, ensuring that no one is left behind.
This content aligns with Goal 3: Good Health by advocating for a deeper understanding of neurodevelopmental conditions, such as Down syndrome, through a process-based approach that recognizes the dynamic and interdependent nature of development. By shifting the focus from static classifications to understanding the interactions and processes that contribute to neurodiversity, the paper promotes better health outcomes through more effective interventions and support strategies for individuals with these conditions. Additionally, it supports Goal 10: Reduced Inequalities by addressing the limitations of traditional research methods, which can marginalize the experiences of neurodiverse individuals, and by advocating for inclusive research practices that consider diverse perspectives and promote equity in the understanding and treatment of neurodevelopmental conditions.
Elsevier,

Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, pp 71-87

This content aligns with Goal 3: Good Health and Well-being, Goal 5: Gender Equality, and Goal 9: Industry, Innovation, and Infrastructure by discussing the potential for digital health technologies to exacerbate existing systemic and structure inequalities, and the ways in which we can avoid this.
Elsevier,

Resilient Health: Leveraging Technology and Social Innovations to Transform Healthcare for COVID-19 Recovery and Beyond, 2024, pp 1085-1098

This content aligns with Goal 3: Good Health and Well-being, Goal 5: Gender Equality, and Goal 9: Industry, Innovation, and Infrastructure by considering how modern digital health strategies can reduce healthcare inequities and close the health treatment gap for remote, underserved communities.
Elsevier,

Tryptamine Microbiota-Deregulated Aminoacyl-tRNA Biosynthesis: A Conceptual Evolution of the Role of Microbiota Tryptamine in Human Diseases, 2024, pp 253-267

This content aligns with Goal 3: Good Health and Wellbeing and Goal 9: Industry, Innovation, and Infrastructure by highlighting the data demonstrating the role tryptamine plays in Alzheimer's Disease.

Pages